HSF1 Protein Guards Aging Muscles Through a Key Mitochondrial Pathway

Age-related sarcopenia—progressive loss of skeletal muscle mass and function—affects millions of older adults and drives insulin resistance, fatty liver, and reduced quality of life. Despite intensive research, no single molecular regulator has been identified that simultaneously addresses both muscle fiber atrophy and mitochondrial dysfunction during aging. This study positions Heat Shock Factor 1 (HSF1), a transcription factor best known for its role in the heat-shock response and protein quality control, as a central player in that dual protection.

The authors first established clinical and biological relevance by showing that HSF1 mRNA levels are significantly reduced in hindlimb and gastrocnemius muscles of aged mice—confirmed via GEO database analysis (GSE75523) and in-house samples—and in human skeletal muscle biopsies from older individuals. HSF1 expression negatively correlated with myostatin (MSTN), a canonical muscle atrophy marker, and positively correlated with TFAM, a key mitochondrial biogenesis gene, suggesting HSF1 sits at the intersection of muscle mass regulation and mitochondrial health.

Using muscle-specific HSF1 knockout mice aged to simulate sarcopenia, the team observed severe muscle atrophy, reduced endurance capacity, smaller fast-twitch fibers, and mitochondrial dysfunction specifically in slow-twitch oxidative fibers—alongside impaired systemic metabolism including insulin resistance. Conversely, skeletal muscle-specific overexpression of a constitutively active form of HSF1 improved muscle mass, fiber size, mitochondrial function, and whole-body metabolic performance in aged animals.

To uncover the molecular mechanism, the researchers combined RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) in skeletal muscle. They identified SIRT3—a mitochondrial deacetylase—as a direct transcriptional target of HSF1. SIRT3, in turn, deacetylated both PGC1α1 (which drives mitochondrial biogenesis and oxidative metabolism) and PGC1α4 (which promotes muscle hypertrophy), activating both isoforms in a fiber-type-specific manner. This HSF1→SIRT3→PGC1α axis also elevated FNDC5/Irisin, a myokine that signals from muscle to adipose tissue, potentially mediating beneficial inter-organ crosstalk and contributing to improved systemic energy homeostasis.

These findings are significant because they link a stress-response transcription factor to two distinct but interconnected problems in aging muscle—proteostasis and mitochondrial function—through a single downstream pathway. While the work is primarily in mouse models with supporting human correlational data, it provides a mechanistic framework and identifies HSF1 and SIRT3 as tractable therapeutic targets. Small-molecule HSF1 activators or SIRT3 agonists could represent viable strategies for treating sarcopenia and its metabolic co-morbidities in aging populations.